Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

Differential phosphorylation of Akt1 and Akt2 by protein kinase CK2 may account for isoform specific functions.

  • Cristina Girardi
  • Peter James
  • Sofia Zanin
  • Lorenzo A Pinna
  • Maria Ruzzene
Publishing year: 2014
Language: English
Pages: 1865-1874
Publication/Series: Biochimica et Biophysica Acta
Volume: 1843
Issue: 9
Document type: Journal article
Publisher: Elsevier

Abstract english

Akt (also known as PKB) is a survival kinase frequently up-regulated in cancer; three isoforms of Akt exist, and among them Akt1 and Akt2 are the most widely and highly expressed. They share the same structure and activation mechanism and have many overlapping functions; nevertheless isoform-specific roles and substrates have been reported, which are expected to rely on sequence diversities. In particular, a special role in differentiating Akt1 and Akt2 isoforms has been assigned to the linker region, a short segment between the PH and the catalytic domains. We have previously found that a residue in the linker region (Ser129) is directly phosphorylated by protein kinase CK2 in Akt1; the phosphorylation of the homologous residue in Akt2 (Ser131) has never been analyzed. Here we show that Akt2, endogenously or ectopically expressed in different cell lines, is not phosphorylated on Ser131 by CK2, while in vitro recombinant Akt2 is a CK2 substrate. These data support the hypothesis that in vivo a steric hindrance occurs which prevents the access to the CK2 site. Additionally, we have found that Ser129 phosphorylation is involved in the recognition of the Akt1-specific substrate palladin; this observation provides an explanation of why Akt2, lacking Ser131 phosphorylation in the linker region, has a low efficiency in targeting palladin. CK2-dependent phosphorylation is therefore a crucial event which, discriminating between Akt1 and Akt2, can account for different substrate specificity, and, more in general, for fine tuning of Akt activity in the control of isoform-dependent processes.


  • Biological Sciences


  • ISSN: 0006-3002
Peter James
E-mail: peter [dot] james [at] immun [dot] lth [dot] se


Department of Immunotechnology

+46 46 222 14 96

+46 70 247 79 60